Tag Archives: Adverse Drug Reactions in the Elderly

System to Measure and Prevent Medication Errors Under Development (Department of Health and Social Care / EEPRU / BBC News)

Posted on May 12, 2018 by Dementia and Elderly Care News

Summary The Department of Health and Social Care now has a system to help identify, monitor and prevent medication errors. The aim is to help ensure the NHS becomes the safest healthcare system in the world, as well as avoiding … Continue reading →

Posted in Acute Hospitals, Commissioning, Community Care, Department of Health, Department of Health and Social Care (DHSC), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest, World Health Organization (WHO) | Tagged Adverse Drug Reactions, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Avoidable Admissions, Avoidable Harm, Avoidable Hospital Admissions, Avoidable Ill-Health, Avoidable Mortality, Avoidable Premature Mortality, Avoidable Rehospitalisations, Caroline Dinenage: Care Minister, Choosing Wisely, Choosing Wisely Campaign, Community Pharmacists, Continuous Learning Culture, Culture Change, Culture of Raising Concerns, Defences for Pharmacists: Accidental Dispensing Errors, Department of Health and Social Care (Formerly the Department of Health), Electronic Prescribing and Medicines Administration (EPMA), Electronic Prescribing Systems, ePACT2, Epidemiology and Statistics, Gastric Bleed Statistics, Global Patient Safety Challenge (WHO), Hospital Admissions, Hospital Electronic Prescribing and Medicines Administration (HePMA), Inappropriate Hospital Admissions, Learning Culture, Measurement and Prevention of Medication Errors, Medication Errors, Medication Errors and Adverse Drug Reactions, Medication Reviews, Medication Safety, Medication Safety Dashboard, Medication Without Harm (WHO), Medicines Optimisation, Medicines Optimisation Dashboard, Medicines Safety Programme (WHO), NHS Culture Change, NHS England Medicines Optimisation Intelligence Group, NHS Patient Safety Culture, NHS Specialist Pharmacy Service, NHS: Safest Healthcare System in the World (Ambition), No Harm Culture, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Without Gastro Protective Medicine, Openness and Honesty When Things Go Wrong, Openness and Transparency, Patient Safety, Patient Safety Improvement, Patient Safety Indicators, Patient Safety Strategies, Patients With Polypharmacy Risks, Pharmacist-Led Medication Reviews, Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU), Polypharmacy, Preventable Deaths in English Acute Hospitals, Preventable Hospital Admissions, Preventable Hospital Deaths, Preventable Hospital Mortality, Preventable Mortality, Preventing Avoidable Emergency Admissions, Primary Care Adverse Drug Reactions, Putting Patients First, Quality Improvement, Quality Improvement Culture, Reducing Inappropriate Polypharmacy, Reducing Litigation Costs, Reducing Waste in the NHS, Regular Medication Reviews, Report of the Short Life Working Group on Reducing Medication-Related Harm, Reporting Culture, Reporting of Incidents, Research on Medication Error, Royal Pharmaceutical Society (RPS), ScHARR: University of Sheffield, School of Health and Related Research (ScHARR): University of Sheffield, Short Life Working Group on Reducing Medication-Related Harm, Stop the Over-Medication of People With a Learning Disability or Autism (STOMP) Campaign, Transparency, Transparency and Accountability, Transparent Learning Culture, Unnecessary Hospital Admissions | Leave a comment

Medication Errors: an Open Learning Culture Recommended to Reduce Patient Harm (BBC News / Department of Health / EEPRU / Department of Health and Social Care)

Posted on February 25, 2018 by Dementia and Elderly Care News

Summary Medication errors, which include (i) wrong medications given, (ii) incorrect doses and (iii) delays in medication being administered, cause an estimated 700 deaths per year and might play a role in something between 1,700 to 22,300 further avoidable deaths. … Continue reading →

Posted in Acute Hospitals, BBC News, Commissioning, Community Care, Department of Health, Department of Health and Social Care (DHSC), For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, Management of Condition, National, NHS, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest, World Health Organization (WHO) | Tagged Acute Care and Quality, Acute Care and Workforce, Adult Psychiatric Intensive Care Services, Adverse Drug Reactions, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, BBC Health News, Blame Culture, Care Home Culture, Care Home Environments, Care Homes, Centre for Health Economics: University of York, Choosing Wisely Campaign, Choosing Wisely in the NHS, CHUMS Study, Clinical Pharmacists, Clinical Responsibility for Patients (Choosing Wisely and New Deal), Community Pharmacists, Continuous Learning Culture, CQC Investigations and Quality Policy, Culture and Behaviour Change, Culture and Leadership, Culture Change, Culture of Raising Concerns, Department of Health Policy Research Programme, Division of Population Health Health Services Research and Primary Care: University of Manchester, Electronic Prescribing and Medicines Administration (EPMA), Electronic Prescribing Systems, EQUIP Study, Former Health Secretary Jeremy Hunt, Global Patient Safety Challenge (WHO), HePMA, Hospital E-Prescribing and Medicines Administration, Hospital Electronic Prescribing and Medicines Administration (HePMA), Hospital Pharmacists, Learning Culture, Making Choices Together (Previously Choosing Wisely Wales), Manchester Centre for Health Economics: University of Manchester, Medication Errors, Medication Errors and Adverse Drug Reactions, Medication Without Harm (WHO), Medicines Safety Programme (WHO), Medicines Value Programme (NHS England), NHS Culture, NHS Culture Change, NHS Patient Safety Culture, NHS Specialist Pharmacy Service, No Harm Culture, Old Age Psychiatry, Open and Transparent Culture, Openness, Openness and Collaboration, Openness and Honesty When Things Go Wrong, Openness and Transparency, Partnering with Patients and Families, Patient and Family Engagement, Patient and Public Engagement (PPE), Patient and Public Involvement, Patient and Public Involvement (PPI), Patient Engagement, Patient Engagement Strategies, Patient Harm, Patient Harms and Harm Free Care, Patient Safety, Patient Safety Champions, Patient Safety Improvement, Patient Safety Indicators, Patient Safety Strategies, Patients With Polypharmacy Risks, Pharmacist Buddy Scheme (County Durham and Darlington NHS Foundation Trust), Pharmacist-Led Information Technology Intervention (PINCER), Pharmacists, PINCER Intervention, Policy Research Programme (PRP), Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU), Polypharmacy, Potentially Preventable Complications in Hospitalis, PREPARE: Partnership for Responsive Policy Analysis and Research, PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) Study, Prescription Errors in Psychiatry, Preventable Deaths in English Acute Hospitals, Preventable Hospital Deaths, Preventable Hospital Mortality, Preventable Mortality, Primary Care Adverse Drug Reactions, PROTECT Programme, Putting Patients First, Quality Improvement Culture, Reducing Inappropriate Polypharmacy, Reducing Litigation Costs, Report of the Short Life Working Group on Reducing Medication-Related Harm, Reporting Culture, Reporting of Incidents, Research on Medication Error, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health and Social Care, ScHARR: University of Sheffield, School of Health and Related Research (ScHARR): University of Sheffield, SDM: Shared Decision Making, Secondary Care Adverse Drug Reactions, Serious Mistakes, Severe Harm, Shared Care and Education, Shared Decision-Making, Short Life Working Group (SLWG), Short Life Working Group on Reducing Medication-Related Harm, Stop the Over-Medication of People With a Learning Disability or Autism (STOMP) Campaign, Transparency, Transparency and Accountability, Transparent Learning Culture, UK Department of Health Policy Research Programme, United States National Coordinating Council for Medication Error Reporting and Prevention, University of Manchester, University of Sheffield, University of York, University of York Centre for Health Economics (CHE), WHO Domain: Health Care Professionals, WHO Domain: Medicines, WHO Domain: Patients and the Public, WHO Domain: Systems and Practice of Medication, WHO Domains, WHO Global Patient Safety Challenge | Leave a comment

Reducing Under-Usage of Medications (British Journal of Clinical Pharmacology)

Posted on June 22, 2017 by Dementia and Elderly Care News

Summary A meta-analysis investigating the impact of pharmaceutical care interventions for medication underuse in older people has shown that such interventions, including medication reviews, can reduce medication under-use in older people. Full Text Link Reference Meid, AD. Lampert, A. [and] … Continue reading →

Posted in Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, Systematic Reviews, Universal Interest | Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Ageing Population, Assessing Care of Vulnerable Elderly (ACOVE), Assessment of Underutilization (AOU) Index, British Journal of Clinical Pharmacology, Clinical Pharmacists, Community Pharmacists, Cooperation Unit Clinical Pharmacy: University of Heidelberg, Department of Clinical Pharmacology and Pharmacoepidemiology: University of Heidelberg, Germany, Good Prescribing, Medication Errors and Adverse Drug Reactions, Medication Reviews, Medication Underuse in Older People, Medication-Related Problems in the Elderly, Medications Under-Use, Optimisation of Pharmacotherapy in Older People, Pharmacist-Led Medication Reviews, Pharmacists, Polypharmacy in the Elderly STOPP and START Criteria, Potentially Inappropriate Prescribing (PIP), Reducing Under-Usage of Medications, School of Pharmacy: University of Colorado Anschutz Medical Campus, Screening Tool to Alert Doctors to Right Treatments (START), STOPP (Screening Tool of Older Person's Prescriptions), STOPP and START Criteria, Sub-Optimal Prescribing in Older Inpatients and Outpatients, Systematic Reviews and Meta-Analyses, Under-Usage of Medications, Undermedication, United States, University of Colorado, University of Heidelberg, USA | Leave a comment

Aspirin: Stomach Bleeds Risk for Over-75s (BBC News / Lancet / NHS Choices)

Posted on June 15, 2017 by Dementia and Elderly Care News

Summary Persons aged over 75 taking daily aspirin following a stroke or heart attack are at higher risk of stomach bleeds than thought previously. The benefits of low dose aspirin still outweigh the risks, even in this age group. Co-prescription … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged adverse, Adverse Drug Events, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Adverse Events, Aspirin, Aspirin: Low-Dose Acetylsalicylic Acid, Aspirin: Stomach Bleeds Risk for Over-75s, BBC Health News, Behind the Headlines, Centre for Prevention of Stroke and Dementia: University of Oxford, Daily Low-Dose Aspirin, Gastrointestinal Bleeding, John Radcliffe Hospital, Lancet, Nuffield Department of Clinical Neurosciences: University of Oxford, Oxford Vascular Study, Oxford Vascular Study (OXVASC), Prophylactic Use of Aspirin, Proton Pump Inhibitors (PPIs), University of Oxford | Leave a comment

Patient Safety Improvement in Care Homes (BMC Health Services Research)

Posted on February 3, 2017 by Dementia and Elderly Care News

Summary A programme to improve patient / resident safety in care homes is to be conducted in Walsall and Wolverhampton over 24 months. This article outlines the evaluation of this care home improvement programme in the West Midlands. The aim is … Continue reading →

Posted in Commissioning, Community Care, Falls, Falls Prevention, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest, Wolverhampton | Tagged Adverse Drug Reaction / Error Champions, Adverse Drug Reactions, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Safety Events, Avoidable Acute Hospital Admission in Older People, BMC Health Services Research, Care Home Culture, Care Home Environments, Care Homes, Changes in Safety Practices (Care Home Level), Changes in Safety Practices (Staff Level), CLAHRCs: NIHR Collaborations for Leadership in Applied Health Research and Care, Collaboration for Leadership in Applied Health Research and Care (CLAHRC), College of Medical and Dental Sciences: University of Birmingham, Culture of Safety, Dementia Education, Dementia Training, Education and Training, Hospital Activity, Improving Patient Safety, Inappropriate Hospital Admissions, Infection Control, Institute of Applied Health Research: University of Birmingham, Institute of Health Professions: University of Wolverhampton, Local AHSNs, Local Patient Safety Collaboratives, Medication Errors, Meridian Online Health Innovation Exchange, NHS England's Sign Up to Safety Campaign, NHS Walsall CCG, NHS Wolverhampton CCG, NIHR CLAHRC West Midlands, Opportunities to Treat Patients Without Hospital Admission, Patient Safety, Patient Safety Collaborative Programmes, Patient Safety Collaboratives, Patient Safety Collaboratives Programme, Positive Approaches to Care (PAC), Pressure Ulcers, Pressure Ulcers: Prevention, Preventable Hospital Admissions, Primary Health Care (Journal), Quality and Safety Improvement Approaches in Care Homes, Quality Improvement, Quality of Life for People Living in Care Homes, Research in Care Homes, Safer Provision and Caring Excellence (SPACE) Programme, Safety Attitudes Questionnaire (SAQ), Safety Improvement in Care Homes, Sign up to Safety, Sign Up to Safety Campaign, Skills and Training, SPACE Programme (WMAHSN), Staff Training, Training and Support, Transfer of Medicines, University of Birmingham, University of Wolverhampton, Unnecessary Hospital Admissions, Unplanned Hospital Admissions, Urinary Tract Infections (UTIs), Walsall, Walsall and Wolverhampton Care Home Improvement Programme, Walsall and Wolverhampton Clinical Commissioning Groups (CCGs), Wellbeing in Care Homes, West Midlands, West Midlands Patient Safety Collaborative (PSC), Wolverhampton, Workforce Competencies, Workforce Training | Leave a comment

Introducing the Journal of Geriatric Care and Research (JGCR)

Posted on July 3, 2016 by Dementia and Elderly Care News

Summary The Journal of Geriatric Care and Research (ISSN 2397-5628) is a recently launched, locally edited, multi-disciplinary peer-reviewed international journal, which covers topics of relevance to the care of the elderly. Concerning Guidelines on the Use of Antipsychotics for Agitation … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, International, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Pharmacological Treatments, Quick Insights, Wales, Wolverhampton | Tagged Academia.edu, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Agitation, Agitation and Aggression, Alternatives to Antipsychotics, Alzheimer’s Disease-Related Agitation, American Journal of Psychiatry, American Psychiatric Association (APA), American Psychiatric Association: Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia (2016), Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, APA Practice Guidelines, Aripiprazole, Atypical Antipsychotics, Avoidable Harm, Avoidable Hospital Mortality, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Benefits and Risks of Antipsychotic Treatment, Betsi Cadwaladr University Health Board, Black Country, Black Country Partnership NHS Foundation Trust, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Indian Psychiatric Association (BIPA), Community and Mental Health Trusts, Dr Sarmishtha Bhattacharyya: Consultant in Old Age Psychiatry at Wrexham Maelor Hospital, Faculty of Health and Social Care: University of Chester, Geriatric Care and Research Organisation (GeriCaRe), Haloperidol, Improving Prescribing Practice, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Journal of Geriatric Care and Research (JGCR), Learning Disabilities, Medication Reviews, Mental Health Trusts, North Wales, Olanzapine, Over-Medication, Over-Medication for People With Learning Disabilities, Over-Prescribing, Overprescribing, People With Learning Disabilities, Personalised Care Versus Guideline-Based Care, Personalised Medicine Versus Guideline-Based Medicine, Potential Harms of Antipsychotic Use, Potentially Inappropriate Prescribing, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Prescribing of Antipsychotic Drugs For People With Learning Disabilities, Psychosis in Patients With Dementia, Quetiapine, Reducing Agitation and Distress, Reducing Antipsychotic Prescriptions in Dementia, Reducing Avoidable Premature Mortality, Reducing Inappropriate Use of Antipsychotics, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Safe and Compassionate Care, United States, University of Chester, USA, Violence and Aggression, West Midlands, Wrexham, Wrexham Maelor Hospital, Ziprasidone | Leave a comment

Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA / JAMA Psychiatry / BJCP)

Posted on November 6, 2014 by Dementia and Elderly Care News

Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, Statistics, UK | Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions (ADRs): Type A (Potentially Avoidable and Associated With Commonly Prescribed Medications), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Alternatives to Antipsychotics, Antidepressants, Antihypertensives, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Absolute Mortality Risk Increase, Antipsychotics: Neuroleptic Sensitivity, Antipsychotics: Number Needed to Harm (NNH), Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Benzodiazepines, BMJ, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brief Psychosocial Treatment, British Journal of Clinical Pharmacology, British Medical Journal (BMJ), Campbell Institute (CAMH): University of Toronto, Cardiff University, Center for Clinical Management Research: Veterans Affairs Ann Arbor Healthcare System (Michigan), Center for Statistical Consultation and Research: University of Michigan, CitAD Research Group, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Clinical Biotechnology Research Institute: Roper St Francis Healthcare (Charleston: South Carolina), College of Physicians and Surgeons of Columbia University, DART-AD: Dementia Antipsychotic Withdrawal Trial (DART-AD), Dementia Antipsychotic Withdrawal Trial (DART-AD), Department of Psychiatry: University of Michigan, Department of Psychiatry: University of Southern California, Discontinuation of Antipsychotics, Effect of Citalopram on Agitation in Alzheimer Disease (CitAD Randomized Clinical Trial), Falls Prevention, Hotchkiss Brain Institute: University of Calgary, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, International Conference on Harmonization, JAMA, JAMA Psychiatry, Johns Hopkins Bayview and Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health: Baltimore, Kings College London, Medication Reviews, National Institute for Health Research (NIHR): Mental Health Biomedical Research Centre and Dementia Unit, NEST Approach, Neuroleptic Discontinuation, Neuroleptics, New York State Psychiatric Institute, Patients’ Needs and the Environment Stimulation and Techniques (NEST), Perelman School of Medicine: University of Pennsylvania, Personalised Social Interaction, Pharmacokinetics, Polypharmacy, Potential Harms of Antipsychotic Use, Prescribing Anti-Psychotic Drugs to People with Dementia, Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Seattle Protocols, Simulated Presence Therapy, South London and Maudsley NHS Foundation Trust, Stanford University School of Medicine, United States, University Hospital Llandough (Cardiff), University of Calgary, University of Manchester, University of Michigan, University of Pennsylvania, University of Rochester School of Medicine and Dentistry, University of Southern California, University of Southern California Keck School of Medicine, University of Toronto, Violence and Aggression, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Tag Archives: Adverse Drug Reactions in the Elderly

Aspirin: Stomach Bleeds Risk for Over-75s (BBC News / Lancet / NHS Choices)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites